XML 25 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Statement of Comprehensive Income [Abstract]      
Net sales $ 422,670 $ 458,300 $ 704,274
Cost of sales:      
Cost of product (excluding amortization) 121,038 131,323 177,221
Amortization of patented formulations 9,342 8,345 7,500
Total cost of sales 130,380 139,668 184,721
Gross profit 292,290 318,632 519,553
Operating expenses:      
Selling, general, and administrative 181,685 168,942 113,877
Amortization of other intangible assets 43,669 41,468 41,282
Total operating expenses 225,354 210,410 155,159
Operating income 66,936 108,222 364,394
Interest expense 59,585 57,954 43,953
Interest income (25,379) (18,828) (2,775)
Other expense (income), net:      
Loss on extinguishment of debt 0 0 18,803
Tax receivable agreement liability adjustment 3,915 (7,404) (3,084)
Other expense (income), net 1,903 (220) 2,256
Total other expense (income), net 5,818 (7,624) 17,975
Income before provision for income taxes 26,912 76,720 305,241
Income tax provision 7,390 15,133 61,169
Net income $ 19,522 $ 61,587 $ 244,072
Net income per share:      
Net income per share: Basic (in usd per share) $ 0.03 $ 0.09 $ 0.38
Net income per share: Diluted (in usd per share) $ 0.03 $ 0.09 $ 0.35
Weighted average common shares outstanding:      
Weighted average common shares outstanding: Basic (in shares) 661,980,612 654,592,923 649,092,846
Weighted average common shares outstanding: Diluted (in shares) 665,397,655 677,578,245 691,005,846
Other comprehensive (loss) income:      
Unrealized (loss) gain on derivatives, net of income tax effect $ (2,130) $ (1,212) $ 2,577
Total other comprehensive (loss) income (2,130) (1,212) 2,577
Comprehensive income $ 17,392 $ 60,375 $ 246,649